compounded semaglutide no longer available FDA says that the GLP-1 shortage is over Affordable Compounded Semaglutide Injections -

Beyond this BMI range, however, it becomes increasingly unlikely that patients will achieve the level of weight loss necessary for the health outcomes they and their care team hope for with the medication alone

Reassess your diet and exercise routine, adjust your goals, and focus on the other benefits exercise is bringing you, like increased energy or confidence

Phase 3 readouts are expected to inform a regulatory submission, though as of early 2026 Retatrutide is not yet approved by the FDA or EMA

Insurance Coverage We have these revolutionary new treatments that some are calling miracle drugs, but access is limited